Vyome Holdings, Inc. (HIND)

2.25 +0.01 (+0.36%) USD  |  NASDAQ  |  Aug 25, 16:00
2.25 0.00 (0.00%) After-Hours: 19:12
More

Vyome Holdings Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for HIND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2025. Start Trial.
Date Value
May 29, 2026 --
May 19, 2026 --
May 04, 2026 --
Date Value
March 25, 2026 --
November 18, 2025 --
October 02, 2025 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Cardiac Biotech Solutions, Inc. --
Anika Therapeutics, Inc. Upgrade
Enovis Corp. Upgrade
Edwards Lifesciences Corp. Upgrade
Perspective Therapeutics, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade